Related Experiment Video
Updated: May 22, 2026
09:04
A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
Selectively guanidinylated aminoglycosides as antibiotics
Richard J Fair1, Mary E Hensler, Wdee Thienphrapa
1Department of Chemistry & Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Chemmedchem
|May 29, 2012
Summary
Researchers developed novel guanidino-aminoglycosides to combat drug-resistant bacteria. These semisynthetic antibiotics show enhanced binding to bacterial ribosomes and improved efficacy against strains like methicillin-resistant Staphylococcus aureus (MRSA).
Area of Science:
- Medicinal Chemistry
- Microbiology
- Molecular Biology
Background:
- Rising threat of virulent, drug-resistant bacterial strains necessitates urgent antibacterial research.
- Limited pipeline of new antibacterial pharmaceutical agents exacerbates the challenge.
- Aminoglycosides, a potent class of natural antibiotics, offer a promising scaffold for developing novel semisynthetic compounds.
Purpose of the Study:
- To explore the development of next-generation aminoglycoside antibiotics through targeted chemical modification.
- To synthesize and evaluate semisynthetic aminoglycoside derivatives with enhanced antibacterial properties.
Main Methods:
- Synthesis of a small library of aminoglycoside derivatives with selective guanidine group modifications.
- Assessment of binding affinity to the ribosomal decoding rRNA A-site using in vitro fluorescence resonance energy transfer (FRET) assays.
- Determination of minimum inhibitory concentration (MIC) values against various resistant bacterial strains.
Main Results:
- Most synthesized guanidino-aminoglycosides exhibited increased binding affinity to the ribosomal A-site compared to parent compounds.
- Several analogues demonstrated improved MIC values against resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA).
- A specific amikacin derivative showed comparable or superior activity against a majority of tested bacterial strains.
Conclusions:
- Selective guanidine modification of aminoglycosides is a viable strategy for developing next-generation antibacterial agents.
- The enhanced binding affinity and improved MIC values highlight the therapeutic potential of these semisynthetic derivatives.
- Further investigation into promising analogues, such as the amikacin derivative, is warranted for clinical development.
Related Concept Videos
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
00:57Antibiotic Selection
Overview
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...